2. Gene
  3. Calu - calumenin Gene

Calu - calumenin Gene

  • Gene
  • Protein
  • Agent
  • Ortholog
Rattus norvegicus

Also known as Rcn; Cbp50

Gene ID: 64366 | Gene type: protein coding

About Calu

Summary

Enables calcium ion binding activity; enzyme binding activity; and enzyme inhibitor activity. Involved in peripheral nervous system axon regeneration and response to organic cyclic compound. Located in endoplasmic reticulum lumen. Orthologous to human CALU (calumenin). [provided by Alliance of Genome Resources, Apr 2022]

Calu Products(2)

mRNA Protein Name
NM_001033898.1 NP_001029070.1 calumenin isoform b precursor
NM_022535.2 NP_071980.2 calumenin isoform a precursor
Gene Ontology
  • Molecular Function
  • Biological Process
  • Cellular Component
Molecular Function GO Annotation Evidence Reference Source
enables calcium ion binding IDA
IDA: Inferred from direct assay
8416973 RGD
enables enzyme binding IDA
IDA: Inferred from direct assay
15075329 RGD
enables enzyme inhibitor activity IDA
IDA: Inferred from direct assay
15075329 RGD
Biological Process GO Annotation Evidence Reference Source
involved in peripheral nervous system axon regeneration IEP
IEP: Inferred from expression pattern
15509515 RGD
involved in response to organic cyclic compound IEP
IEP: Inferred from expression pattern
17994578 RGD
Cellular Component GO Annotation Evidence Reference Source
located in endoplasmic reticulum lumen IDA
IDA: Inferred from direct assay
8416973 RGD
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern
Protein Preferred Names Protein Names

calumenin

CBP-50

crocalbin

reticulocalbin

Related Agents

Clinical Phase
Inhibitory Antibodies (1)
Cat. No. Product Name Effect
Purity Phase
HY-P991233 BAT1006 Inhibitor / Phase 2
Pre-clinical Phase
Bioactive Molecules (24)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-168664 CPD-39 Degrader 98.06% Unkown
HY-137246 CD73-IN-3 Inhibitor 99.89% Unkown
HY-168660 CPD-10 / Unkown
HY-144269 SHR902275 Inhibitor / Unkown
HY-149304 SARS-CoV-2-IN-40 Inhibitor / Unkown
HY-155014 SARS-CoV-2-IN-44 Inhibitor / Unkown
HY-155015 SARS-CoV-2-IN-45 Inhibitor / Unkown
HY-155016 SARS-CoV-2-IN-46 Inhibitor 99.77% Unkown
HY-156325 SARS-CoV-2-IN-62 Inhibitor / Unkown
HY-156337 SARS-CoV-2-IN-63 Inhibitor / Unkown
HY-156441 SARS-CoV-2-IN-65 Inhibitor / Unkown
HY-162313 NIP-22c Inhibitor / Unkown
HY-162492 Influenza A virus-IN-14 Inhibitor / Unkown
HY-162719 RH12 Inhibitor / Unkown
HY-168917 9-AMN Inhibitor / Unkown
HY-170850 MKLP2-IN-1 Inhibitor / Unkown
HY-RS01849 CALU Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-157805 PROTAC SARS-CoV-2 Mpro degrader-2 Degrader / Unkown
HY-163206 SARS-CoV-2-IN-77 Inhibitor / Unkown
HY-173459 N-0920 Inhibitor / Unkown
HY-176280 SARS-CoV-2-IN-115 Inhibitor / Unkown
HY-N1107 Uzarigenin / Unkown
HY-RS19578 Calu Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS26075 Calu Rat Pre-designed siRNA Set A Pre-designed Set / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens Calu NCBI NCBI:813
Mus musculus Calu NCBI NCBI:12321